ACM
KALA icon

AIGH Capital Management’s KALA BIO KALA Stock Holding History

AIGH Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,000
Closed -$1.43M – 47
2025
Q2 		$1.43M Buy
6,000
+2,073
+53% +$404K 0.64% 26
2025
Q1 		$1.13M Buy
3,927
+1,501
+62% +$568K 0.47% 34
2024
Q4 		$842K Buy
+2,426
New +$765K 0.26% 33

Other funds holding KALA

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AIGH Capital Management's KALA Position: Q3 2025 in Review

AIGH Capital Management sold out of KALA BIO (KALA) in Q3 2025, closing a stake of 6,000 shares — an estimated $1.43M sold.

AIGH Capital Management first reported a position in KALA in Q4 2024 and held it in 3 quarters. The position peaked at $1.43M in Q2 2025. 22 funds tracked by Wall St. Rank hold KALA as of Q3 2025.

  • AIGH Capital Management reported no remaining KALA BIO position as of Q3 2025 after selling out during the quarter.
  • AIGH Capital Management sold 6,000 KALA BIO shares in Q3 2025, an estimated $1.43M.
  • AIGH Capital Management first reported a position in KALA BIO in Q4 2024 and held it in 3 quarters.
  • AIGH Capital Management's KALA BIO position peaked at $1.43M in Q2 2025.
  • 22 funds tracked by Wall St. Rank held KALA BIO as of Q3 2025.

Based on AIGH Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.